Tardive dyskinesia and tardive dystonia with second-generation antipsychotics in non-elderly schizophrenic patients unexposed to first-generation antipsychotics a cross-sectional and retrospective study

Journal of Clinical Psychopharmacology

Volumn 35, Issue 1, 2015, Pages 13-21

  Ryu, Seunghyong ^a   Yoo, Jae Hyun ^a   Kim, Joo Hyun ^a   Choi, Ji Sun ^b   Baek, Ji Hyun ^a   Ha, Kyooseob ^c,d   Kwon, Jun Soo ^d   Hong, Kyung Sue ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

Obsessive compulsive syndrome; Schizophrenia; Second generation antipsychotics; Tardive dyskinesia; Tardive dystonia

Indexed keywords

AMISULPRIDE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZODIAZEPINE DERIVATIVE; CLOZAPINE; MOOD STABILIZER; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; ZIPRASIDONE; ANTIPSYCHOTIC AGENTS;

ADULT; ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DRUG EXPOSURE; DYSTONIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MENTAL PATIENT; OBSESSIVE COMPULSIVE DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RETROSPECTIVE STUDY; SCHIZOPHRENIA; TARDIVE DYSKINESIA; TARDIVE DYSTONIA; TORTICOLLIS; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; HUMANS; MIDDLE AGED; MOVEMENT DISORDERS; RETROSPECTIVE STUDIES; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; MOVEMENT DISORDERS; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84925780784     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0000000000000250     Document Type: Article

References (35)

1. Sachdev PS. Neuroleptic-induced movement disorders: an overview. Psychiatr Clin North Am. 2005;28:255-274, x.
2. Meyer JM. Antipsychotic safety and efficacy concerns. J Clin Psychiatry. 2007;68(suppl 14):20-26.
3. Yassa R, Jeste DV. Gender differences in tardive dyskinesia: a critical review of the literature. Schizophr Bull. 1992;18:701-715.
4. Glazer WM. Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. J Clin Psychiatry. 2000;61(suppl 4):15-20.
5. Hong KS, Cheong SS, Woo JM, et al. Risperidone-induced tardive dyskinesia. Am J Psychiatry. 1999;156:1290.
6. Rosenquist KJ, Walker SS, Ghaemi SN. Tardive dyskinesia and ziprasidone. Am J Psychiatry. 2002;159:1436.
7. Bella VL, Piccoli F. Olanzepine-induced tardive dyskinesia. Br J Psychiatry. 2003;182:81-82.
8. Correll CU, Leucht S, Kane JM. Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry. 2004;161:414-425.
9. Correll CU, Schenk EM. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry. 2008;21:151-156.
10. Woods SW, Morgenstern H, Saksa JR, et al. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry. 2010;71:463-474.
11. FitzGerald PM, Jankovic J. Tardive oculogyric crises. Neurology. 1989;39: 1434-1437.
12. van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull. 1999;25: 741-748.
13. Bassitt DP, de Souza Lobo Garcia L. Risperidone-induced tardive dyskinesia. Pharmacopsychiatry. 2000;33:155-156.
14. Papapetropoulos S, Wheeler S, Singer C. Tardive dystonia associated with ziprasidone. Am J Psychiatry. 2005;162:2191.
15. Sevincok L, Balci V, AkyildizU. Tardive dystonia associatedwith low-dose of amisulpride: a case report. J Clin Psychopharmacol. 2008;28:573-574.
16. Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord. 2006;21:589-598.
17. van Harten PN, Matroos GE, Hoek HW, et al. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia. The Curacao Extrapyramidal Syndromes Study: I. Schizophr Res. 1996; 19:195-203.
18. van Harten PN, Hoek HW, Matroos GE, et al. The inter-relationships of tardive dyskinesia, parkinsonism, akathisia and tardive dystonia: the Curacao Extrapyramidal Syndromes Study II. Schizophr Res. 1997;26: 235-242.
19. Jeste DV. Tardive dyskinesia rates with atypical antipsychotics in older adults. J Clin Psychiatry. 2004;65(suppl 9):21-24.
20. Guy W. Ecdeu Assessment Manual for Psychopharmacology (Revised). Rockville, MD: National Institute of Mental Health, Psychopharmacology Research Branch; 1976.
21. Chouinard G, Ross-Chouinard A, Annable L, et al. Extrapyramidal Symptom Rating Scale. Can J Neurol Sci. 1980;7:233.
22. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry. 1982;39:486-487.
23. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology. 1982;32: 1335-1346.
24. Lim M, Park DY, Kwon JS, et al. Prevalence and clinical characteristics of obsessive-compulsive symptoms associated with atypical antipsychotics. J Clin Psychopharmacol. 2007;27:712-713.
25. Kwon JS, Joo YH, Nam HJ, et al. Association of the glutamate transporter gene SLC1A1 with atypical antipsychotics-induced obsessive-compulsive symptoms. Arch Gen Psychiatry. 2009;66:1233-1241.
26. Kruger S, Braunig P, Hoffler J, et al. Prevalence of obsessive-compulsive disorder in schizophrenia and significance of motor symptoms. J Neuropsychiatry Clin Neurosci. 2000;12:16-24.
27. Mukhopadhaya K, Krishnaiah R, Taye T, et al. Obsessive-compulsive disorder in UK clozapine-treated schizophrenia and schizoaffective disorder: a cause for clinical concern. J Psychopharmacol. 2009;23:6-13.
28. Yassa R, Nair V, Schwartz G. Tardive dyskinesia: a two-year follow-up study. Psychosomatics. 1984;25:852-855.
29. Gardos G, Cole JO, Salomon M, et al. Clinical forms of severe tardive dyskinesia. Am J Psychiatry. 1987;144:895-902.
30. Jeste DV, Caligiuri MP. Tardive dyskinesia. Schizophr Bull .1993;19: 303-315.
31. Yadalam KG, Korn ML, Simpson GM. Tardive dystonia: four case histories. J Clin Psychiatry. 1990;51:17-20.
32. Wojcik JD, Falk WE, Fink JS, et al. A review of 32 cases of tardive dystonia. Am J Psychiatry. 1991;148:1055-1059.
33. Sachdev P. Clinical characteristics of 15 patients with tardive dystonia. Am J Psychiatry. 1993;150:498-500.
34. de Leon J. The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study. Eur Arch Psychiatry Clin Neurosci. 2007; 257:169-172.
35. Tarsy D, Simon DK. Dystonia. N Engl J Med. 2006;355:818-829.